Funicular Funds, LP 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-08 6:17 pm Unchanged |
2023-07-06 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 5.590% |
0 (Unchanged) |
Filing |
| 2023-07-06 4:08 pm Unchanged |
2023-07-06 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 9.650% |
0 (Unchanged) |
Filing |
| 2022-09-22 09:01 am Purchase |
2022-09-15 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 9.990% |
15,998 (+24.51%) |
Filing |
| 2022-08-24 4:20 pm Purchase |
2022-08-24 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 65,281 8.000% |
6,826 (+11.68%) |
Filing |
| 2022-07-19 4:30 pm Purchase |
2022-07-15 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 58,455 9.900% |
58,455 (New Position) |
Filing |